Navigation Links
ProFibrix Raises US $11 Million (EUR 8 million) in Series B Financing
Date:8/23/2009

LEIDEN, The Netherlands and SEATTLE, August 24 /PRNewswire/ -- ProFibrix B.V., a leader in the development of innovative products for hemostasis and regenerative medicine, today announced the successful closing of a US $11 million series B investment. The financing round was led by new investor Gilde Healthcare Partners, a leading European life sciences investor, who joins existing investor Index Ventures. Dirk Kersten from Gilde will join the company's Supervisory Board.

Jaap Koopman, PhD, Chief Executive Officer, said: "We are very pleased to welcome Gilde Healthcare to our investor base and we appreciate the ongoing support and expertise that our investors can offer to our experienced team as we continue the development of ProFibrix. The proceeds of the financing will be applied to the ongoing clinical development of our lead product Fibrocaps(TM), and to the preclinical development of our pipeline products."

Fibrocaps is based on a mixture of two essential blood clotting proteins, fibrinogen and thrombin, and is a unique dry powder topical tissue sealant that rapidly stops bleeding after or during surgery. Fibrocaps has major advantages over existing liquid tissue sealants: it is ready for immediate use, is stable at room temperature, highly effective and fast acting. Fibrocaps is currently in a Phase II clinical trial in the Netherlands with results expected end of 2009.

Dirk Kersten, investment manager at Gilde Healthcare Partners, commented: "Gilde Healthcare Partners invests in biopharmaceutical companies with strong technology platforms and experienced management. We believe ProFibrix' breakthrough fibrinogen technology is well-positioned to play an important role in the highly attractive hemostasis and regenerative medicine markets."

ProFibrix expects to submit an Investigational New Drug Application (IND) for Fibrocaps to the U.S. Food and Drug Administration in the f
'/>"/>

SOURCE ProFibrix B.V.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Enobia Raises US$50M from Current Investors in Series C Financing
2. TSH Testing Raises Awareness of Importance of Thyroid Health
3. NeoStem Raises Additional Funds from Principals of Suzhou Erye Pharmaceuticals Company Ltd. and U.S. Institutional and Private Investors, Bringing the Total Recent Financings to Over $15 Million; Funds Will Support Expansion Activities in the United State
4. Gyros Raises SEK 80 Million to Accelerate the Commercialization of its Gyrolab(R) Systems for the Cost-Efficient Development of Biopharmaceuticals
5. Clavis Pharma Raises NOK 129 Million (USD 20 Million) in a Private Placement to Fund Further Development of its Pipeline of Novel Anticancer Drug Candidates
6. Americans United for Life: Obamas Disbanding Bioethics Council Raises Troubling Questions
7. Proteon Therapeutics Completes Second Closing of Equity Financing; Raises Total Series B to $50 million
8. Yongye Biotechnology International Raises $ 9.0 Million In Private Placement, Raises Guidance
9. Marinus Pharmaceuticals Raises $20 Million in Series B Financing
10. BioVex Raises $40 Million in First Close of Series F Financing
11. Moodys Raises Boston Scientifics Rating Outlook to Stable
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... May 21, 2013 NANONEX CORPORATION, ... solutions , today announced the successful delivery and ... system, the NX-M200B, to a major Japanese manufacturing ... a fully-automated, production-ready, advanced nanoimprint lithography tool that ... wafer and substrate sizes and types. Based on ...
(Date:5/21/2013)... Possible mold re-infestation in Guilemtte School sparked concern ... from eagletribune.com posted May 14, 2013, the state is going ... positive, My Cleaning Products offered a tip how to ... was said in the Eagle Tribune report (5.14.13) that the ... after a first-grade classroom was closed due to the high-level ...
(Date:5/21/2013)... Lake, MN (PRWEB) May 21, 2013 The ... trade show display solution for sales and marketing teams looking ... Displays describes the kit as “everything you’ll need to ... Fusion Fabric Display Kit comes with a number of displays ... all-around trade booth 20 feet by 20 feet in size. ...
(Date:5/20/2013)... Al Khaimah, UAE (PRWEB) May 21, 2013 ... private equity consultancy specializing in “game-changing” life science and ... of Ms. Dalia Dergham to its International Project Team. ... to bring even greater multi-cultural depth to Grace Century ... projects around the globe. , Ms. Dergham holds both ...
Breaking Biology Technology:Nanonex Announces the Shipment and Installation of an Innovative Nanoimprint Lithography System for Fully Automated Manufacturing 2Possible Mold Re-infestation Gets Guilmette School Scheduled for Re-inspection, My Cleaning Products Offers Tip How to Kill Mold Safely If Inspection Turns Positive 2Possible Mold Re-infestation Gets Guilmette School Scheduled for Re-inspection, My Cleaning Products Offers Tip How to Kill Mold Safely If Inspection Turns Positive 3GLM Displays Announces All-in-One Formulate Fusion Fabric Display Kit 2Dalia Dergham Joins Grace Century FZ LLC International Project Team 2
... Transgene,(Euronext Paris: FR0005175080) announces promising preliminary data from,the ... as an adjunct to first line chemotherapy in ... This on-going trial is a randomized, open label ... TG4010 in combination with cisplatin and,gemcitabine compared to ...
... full year and fourth quarter 2007 preservation services and, ... to approximately $93.7 million for the year and ... 10 CryoLife, Inc. (NYSE: CRY ),a biomaterials, ... services and product revenues for 2007 were,approximately $93.7 million ...
... Berman Sobol Shapiro LLP,( http://www.hbsslaw.com/cellcyte.htm ) today ... CellCyte (OTC Bulletin Board: CCYG) for potential,violations ... after CellCyte,s shares plunged 55 percent,after news ... Gary,Reys, educational and professional credentials., CellCyte,s ...
Cached Biology Technology:Transgene's Therapeutic Vaccine TG4010 Shows Promising Preliminary Phase IIb Data in Advanced Non-Small Cell Lung Cancer 2Transgene's Therapeutic Vaccine TG4010 Shows Promising Preliminary Phase IIb Data in Advanced Non-Small Cell Lung Cancer 3CryoLife Announces Record Preservation Services and Product Revenues for 2007 2CryoLife Announces Record Preservation Services and Product Revenues for 2007 3CryoLife Announces Record Preservation Services and Product Revenues for 2007 4Hagens Berman Sobol Shapiro Investigating CellCyte 2
(Date:5/17/2013)... residents of all ages will celebrate the science ... on our daily lives during the inaugural Atlanta ... and educators from local museums, corporations, K-12 schools ... 40 different events for children and adults at ... http://atlantasciencefestival.org . , The annual Atlanta Science ...
(Date:5/17/2013)... Federation of American Societies for Experimental Biology (FASEB) released ... Health (NIH) funding trends highlighting the devastating impact of ... The FASEB analysis follows a May 15th Senate Appropriations ... who testified that the $1.6 billion cut the agency ... a substantial impact on the scientific community." , ...
(Date:5/16/2013)... closer to a fast food restaurant had a higher ... away from fast food, according to researchers at The ... association was particularly strong among those with a lower ... the American Journal of Public Health indicates ... food restaurant, and among lower-income African-Americans, the density, or ...
Breaking Biology News(10 mins):First Atlanta Science Festival set for 2014 2Body mass index of low income African-Americans linked to proximity of fast food restaurants 2Body mass index of low income African-Americans linked to proximity of fast food restaurants 3
... - Bacteria are able to build camouflaged homes for themselves inside ... cellular process. , Purdue University ... from the bacteria Legionella pneumophila , which causes Legionnaires disease, ... the cell for use in building and disguising a large structure ...
... This press release is available in French . ... 19th -Century Montreal in two major ways, according to research ... infants from food and water contaminated by fecal bacteria, while ... the health of mothers as well as their subsequent children. ...
... (DOE),s Lawrence Berkeley National Laboratory (Berkeley Lab), through a ... a special line of human breast cells, have found ... ionizing radiation, cancer risks may not be directly proportional ... biological damage from ionizing radiation - the linear-no-threshold hypothesis ...
Cached Biology News:Purdue scientists reveal how bacteria build homes inside healthy cells 2Purdue scientists reveal how bacteria build homes inside healthy cells 3Breastfeeding saved babies in 19th century Montreal 2Breastfeeding saved babies in 19th century Montreal 3New take on impacts of low dose radiation 2New take on impacts of low dose radiation 3New take on impacts of low dose radiation 4
... Kit, 50 purifications. Allows rapid purification ... removal of unincorporated CyDye label and ... yields of labeled cDNA probe. ... labeled by either direct incorporation or ...
... reagents for the isolation of genomic DNA. ... the isolation of genomic DNA from blood. ... the isolation of genomic DNA from plants. ... be used for restriction endonuclease digestion Southern ...
Detects activated caspases in living cells. Simple/sensitive/straight-forward procedure takes only 30 minutes. Results can be analyzed by flow cytometry/fluorescence microscopy/fluorescence plate rea...
Apoptosis Detection Systems and Reagents...
Biology Products: